COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Evaluating the Effectiveness of Interactive SMS Reminders on TB Treatment Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01690754
Recruitment Status : Completed
First Posted : September 24, 2012
Last Update Posted : March 20, 2015
Massachusetts Institute of Technology
Information provided by (Responsible Party):
Shama Mohammed, Interactive Research and Development

Brief Summary:

In this study, Interactive Research and Development (IRD) in Karachi, Pakistan is evaluating the impact of Interactive Reminders on drug compliance and treatment outcomes. Interactive Reminders is an interactive SMS reminder system to help patients remember to take their TB medication. In this system, patients receive daily SMS reminders for the duration of their treatment at a pre-specified time, reminding them to take their medication. Patients are asked to reply back to the system, either through SMS or a missed call, with the time they took their medicine that day. If a response is not received within two hours, a second reminder is sent. If a response is still not received in a further two hours, a third and final reminder for the day is sent. Non-responsive patients are followed up with phone calls and a list of non-responsive patients is shared with clinics based on the parameters of non-responsiveness that they specify.

IRD seeks to determine the impact of this system on treatment outcomes and compliance to prescribed medication through administering a randomized control trial among newly diagnosed TB patients in Karachi, Pakistan.

Condition or disease Intervention/treatment Phase
Tuberculosis Other: Interactive Reminders Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2207 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Monitoring Patient Compliance With Tuberculosis Treatment Regimens
Study Start Date : March 2011
Actual Primary Completion Date : November 2014
Actual Study Completion Date : November 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tuberculosis

Arm Intervention/treatment
No Intervention: Control
This arm will receive the regular standard of care given by TB clinics.
Experimental: Interactive Reminders
Patients randomized to this arm will receive Interactive SMS reminders daily.
Other: Interactive Reminders
Daily SMS reminders sent to TB patients at a pre-specified time. They are asked to respond to the reminders. If a response is not received within two hours, they are sent another reminder for up to three per day.

Primary Outcome Measures :
  1. Treatment Outcomes [ Time Frame: After 6 to 8 months of treatment ]
    The investigators will compare clinically reported treatment outcomes between the intervention and control groups.

Secondary Outcome Measures :
  1. Physical fitness and mobility [ Time Frame: Monthly visits for 6 to 8 months of treatment ]
    The investigators will measure physical fitness and mobility through questionnaires conducted with patients during household visits each month that they are on treatment. The investigators are using two indices. The physical fitness index will record respondents ability to perform certain tasks. The mobility index will record the mobility of participants.

  2. Psychological Impacts [ Time Frame: Monthly visits for 6 to 8 months of treatment ]
    In order to gauge the psychological impacts of the system, the investigators will be looking at participants' perceptions on the likelihood of being cured, how they feel on a given day using the pain scale, and how supported they feel. This data will be collected through questionnaires conducted at each monthly mid-line visit.

  3. Self-reported medication adherence [ Time Frame: "Surprise" monthly visits during treatment ]
    Medication adherence will be measured through self-reports by participants on whether they took their TB medication in the past 24 hours. This data will be collected through monthly "surprise" visits to the participants' houses.

  4. Sputum conversion [ Time Frame: At 1, 2, 5, and 6/7 months of treatment ]
    The investigators will look at sputum test results for patients at months 2, 5, and 6/7 of their treatment to compare when sputum conversion occurs between the intervention and control group at these three periods during their treatment.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   15 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • New, smear-positive drug susceptible TB who have been on treatment for less than two weeks
  • Access to a mobile phone (self-reported)
  • Intending to reside in Karachi for the duration of their treatment

Exclusion Criteria:

  • Patients who do not have regular access to a mobile phone
  • Patients who have previously received TB treatment
  • Patients who have another member in their household who is already a part of the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01690754

Layout table for location information
Civil Hospital
Karachi, Pakistan
Indus Hospital
Karachi, Pakistan
Jinnah Postgraduate Medical Center
Karachi, Pakistan
Landhi Medical Complex
Karachi, Pakistan
Private GP clinics and Private labs partnering with Interactive Research and Devellopment
Karachi, Pakistan
Sindh Government Hospital - Liaqatabad
Karachi, Pakistan
Sindh Government Hospital - New Karachi
Karachi, Pakistan
Sindh Government Hospital - Qatar
Karachi, Pakistan
Sindh Government Hospital New Karachi Kaali Market
Karachi, Pakistan
UHC-New Karachi
Karachi, Pakistan
Urban Health Center - Landhi
Karachi, Pakistan
Sponsors and Collaborators
Interactive Research and Development
Massachusetts Institute of Technology
Layout table for investigator information
Principal Investigator: Rachel Glennerster, PhD. Massachusetts Institute of Technology
Principal Investigator: Shama Mohammed, MPA/ID Interactive Research and Development
Principal Investigator: Aamir J. Khan, MD/PhD. Interactive Research and Development
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Shama Mohammed, Associate Researcher, Interactive Research and Development Identifier: NCT01690754    
Other Study ID Numbers: IRD_IRB_2011_03_002
First Posted: September 24, 2012    Key Record Dates
Last Update Posted: March 20, 2015
Last Verified: March 2015
Keywords provided by Shama Mohammed, Interactive Research and Development:
impact evaluation
Additional relevant MeSH terms:
Layout table for MeSH terms
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections